2021 ´ëÇѵΰæºÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-29±³À°ÀÏÀÚ : 2021-05-29
±³À°Àå¼Ò : ¿ëÆò¸®Á¶Æ®È£ÅÚ 1Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ :
2021 ´ëÇѵΰæºÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѵΰæºÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ±èÀçÈñ
¿¬¶ôó : 031-412-6879
À̸ÞÀÏ :
kshno@hanmail.net ±³À°Á¾·ù : ¿Ü°ú, ¼ºÇü¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
°¿øµµ±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 07:50~08:00 Opening Remarks °ÁøÇü(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 08:00~09:00 Free Paper ()
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 01:00~01:00 Role of HPV Infection in Head and Neck Cancer À̵¿Áø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 09:30~09:50 Mechanism of HPV Vaccine and Current Status of HPV Vaccination ÃÖ¿ø¼®(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 09:50~10:10 Clinical Effect of HPV Vaccine in Preventing Uterine Cervical Cancer ÀÌÀºÁÖ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 10:10~10:30 Clinical Benefit of Vaccinating Male Against HPV-Related Disease À̼¼¿µ(Áß¾ÓÀÇ´ë)
ÈÞ½Ä 05-29 ±×·£µåº¼·ë 10:30~10:50 Coffee Break ()
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 10:50~11:05 Guidance to Outpatient Clinic Considering COVID-19 ¹ÚÁØ¿í(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 11:05~11:20 Practice Guideline for H&N Cancer Radiation Therapy during the COVID-19 Pandemic ¿Àµ¿·Ä(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 11:20~11:35 Head and Neck Cancer Surgery during the COVID-19 Pandemic °íÀ±¿ì(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 11:35~11:50 Medical Oncology of the Head and Neck District during COVID-19 Pandemic ÀÌÀ±±Ô(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 11:50~12:30 Real World Multidisciplinary Treatment for Anaplastic Thyroid Cancer in Japan Naoyoshi Onoda(Kuma Hospital)
ÈÞ½Ä 05-29 ±×·£µåº¼·ë 12:30~13:30 Lunch ()
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 13:30~13:50 Adequate Surgical Extent according to T Stage Á¤ÇѽÅ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 13:50~14:10 Best Communication between Clinicians and Pathologists ÀÌ¿¬¼ö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 14:10~14:30 Virtual Planning for Oromandibular Reconstruction ¹é¿ì¿(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 14:30~14:50 Genomics and Target Therapy ±èÇì·Ã(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 14:50~15:10 Risk Factors for Decisions on Adjuvant Radiation Therapy with/without Concurrent Chemotherapy ÀÌÁ¤½É(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 15:10~15:30 Role of Systemic Therapy in Recurrent/Metastatic Oral Cavity Cancer ¹ÚÁöÇö(°Ç±¹ÀÇ´ë)
ÈÞ½Ä 05-29 ±×·£µåº¼·ë 15:30~15:50 Coffee Break ()
±³À°½Ã°£ 05-29 ±×·£µåº¼·ë 15:50~17:20 Tumor Board: Salivary Gland Cancer °ÀºÁÖ ¿Ü(°í·ÁÀÇ´ë ¿Ü)